Publications by authors named "Nilofer S Azad"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

12,206

Total Likes

618

Extended Reach

1,336,452

Social Features

132
P
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.
Channing J Paller, Lin Wang, Wei Fu, Rajendra Kumar, Jennifer N Durham, Nilofer S Azad, Daniel A Laheru, Ilene Browner, Sushant K Kachhap, Kavya Boyapati

February 2023

Videos about Article: user user user

3 22 3 74

View All Article and Social Media Activity
C
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures.
Kabir Mody, Prerna Jain, Sherif M El-Refai, Nilofer S Azad, Daniel J Zabransky, Marina Baretti, Rachna T Shroff, R Katie Kelley, Anthony B El-Khouiery, Adam J Hockenberry

JCO Precis Oncol· June 2022

Videos about Article: user

1 106 2

View All Article and Social Media Activity
B
Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials.
Fen Saj, Felicity K Namayanja, Lianchun Xiao, Mitesh J Borad, Robin Kate Kelley, Nilofer S Azad

Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations.
H Catherine Wilbur, Heloisa P Soares, Nilofer S Azad

Hepatology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Organ Preservation in Patients With Rectal Cancer After Sequential Short-Course Radiation Therapy and Chemotherapy.
I-Chia Liu, Susan Gearhart, Chen Hu, Haniee Chung, Alodia Gabre-Kidan, Nilofer S Azad

Am Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study.
Jacob S Thomas, Lillian L Siu, Matthew Ingham, Nilofer S Azad, Christian F Meyer

EBioMedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling ADC targets in cholangiocarcinoma: implications for therapeutic development.
Mari Nakazawa, Waqar Arif, Ezra Baraban, Andres Matoso, Elsa Hallab, Nilofer S Azad

NPJ Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma.
Daniel J Zabransky, Emma Kartalia, Jae W Lee, James M Leatherman, Soren Charmsaz, Nilofer S Azad

Hepatology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia.
Melissa R Lyman, Jacob T Mitchell, Sidharth Raghavan, Luciane T Kagohara, Amanda L Huff, Nilofer S Azad

JCI Insight· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting.
Kai-Li Liang, Nilofer S Azad

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.
Marina Baretti, Soumya Shekhar, Vaibhav Sahai, Daniel Shu, Kathryn Howe, Nilofer S Azad

Hepatol Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D.
Jonathan D Schoenfeld, Nilofer S Azad, Jacob Gross, Li Chen, Michael J Overman

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial.
Michael Cecchini, Mary Jo Pilat, Nataliya Uboha, Nilofer S Azad, May Cho

Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic.
Hassan Sinan, Dea Cunningham, Emy Abou Sleiman, Dana Petry, Thomas McPhaul, Nilofer S Azad

JCO Precis Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of recurrence after curative intent hepatic resection for colorectal liver metastasis.
Heng-Chung Kung, Christopher Shubert, Catherine Wilbur, Will Burns, Richard Burkhart, Nilofer S Azad

J Gastrointest Surg· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in Tumors.
Theron Palmer, Michael D Kessler, Xiaoshan M Shao, Archana Balan, Mark Yarchoan, Nilofer S Azad

Cancer Res Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial.
Marina Baretti, Ludmila Danilova, Jennifer N Durham, Courtney B Betts, Leslie Cope, Nilofer S Azad

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Petros Grivas, Elena Garralda, Funda Meric-Bernstam, Ingo K Mellinghoff, Lipika Goyal, Nilofer S Azad

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the promise of RAS inhibition in pancreatic cancer.
Saurav D Haldar, Nilofer S Azad

Nat Rev Gastroenterol Hepatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1.
Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, Gyuri Han, Evangeline Watson, Nilofer S Azad

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Valerie Lee, Rose Parkinson, Marianna Zahurak, Leslie Cope, Andrea Cercek, Nilofer S Azad

Int J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer.
I-Chia Liu, Susan Gearhart, Suqi Ke, Chen Hu, Haniee Chung, Nilofer S Azad

Surg Open Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for the treatment of biliary tract cancer: an evolving landscape.
Helen Catherine Wilbur, Nilofer S Azad

Ther Adv Med Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive single-fraction stereotactic radiation therapy prior to living donor transplantation for inoperable liver-confined metastatic rectal cancer.
Panos A Papanikolaou, Russell N Wesson, Nilofer S Azad, Jeffrey J Meyer

J Radiosurg SBRT· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 T cell-activating neoantigens enhance personalized cancer vaccine efficacy.
Amanda L Huff, Gabriella Longway, Jacob T Mitchell, Lalitya Andaloori, Emily Davis-Marcisak, Nilofer S Azad

JCI Insight· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis.
Amol Gupta, Jane Zorzi, Won Jin Ho, Marina Baretti, Nilofer Saba Azad

Healthcare (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer.
H Catherine Wilbur, Jennifer N Durham, Su Jin Lim, Katrina Purtell, Katherine M Bever, Nilofer S Azad

Cancer Res Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis